ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY AND PSORIASIS

被引：19

作者：

FINNEN, MJ ^{[1
]}

SHUSTER, S ^{[1
]}

LAWRENCE, CM ^{[1
]}

RAWLINS, MD ^{[1
]}

机构：

[1] UNIV NEWCASTLE UPON TYNE, DEPT CLIN PHARMACOL, NEWCASTLE UPON TYNE NG1 4LP, ENGLAND

来源：

BIOCHEMICAL PHARMACOLOGY | 1983年 / 32卷 / 11期

关键词：

D O I：

10.1016/0006-2952(83)90113-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1707 / 1711

页数：5

共 32 条

[1] FACTORS AFFECTING MEASUREMENT OF ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY IN MOUSE SKIN [J].

AKIN, FJ ;

NORRED, WP .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1976, 67 (06) :709-712

[2]

ALVARES AP, 1973, CLIN PHARMACOL THER, V14, P30

[3] HUMAN-SKIN ARYL-HYDROCARBON HYDROXYLASE - INDUCTION BY COAL-TAR [J].

BICKERS, DR ;

KAPPAS, A .

JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (05) :1061-1068

[4] ACTIVITY OF ARYL-HYDROCARBON HYDROXYLASE IN ADULT HUMAN-SKIN [J].

CHAPMAN, PH ;

RAWLINS, MD ;

SHUSTER, S .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (05) :499-503

[5] GENERALIZED TISSUE ABNORMALITY OF ARYL-HYDROCARBON HYDROXYLASE IN PSORIASIS [J].

CHAPMAN, PH ;

KERSEY, PJ ;

KEYS, B ;

SHUSTER, S ;

RAWLINS, MD .

BRITISH MEDICAL JOURNAL, 1980, 281 (6251) :1315-1316

[6]

CHAPMAN PH, 1979, LANCET, V1, P297

[7] ANTIPYRINE CLEARANCE IN PSORIASIS [J].

CHAPMAN, PH ;

KEYS, B ;

RAWLINS, MD ;

MOSS, C ;

SHUSTER, S .

BRITISH MEDICAL JOURNAL, 1981, 282 (6257) :20-21

[8]

CHAPMAN PH, 1979, J INVEST DERMATOL, V72, P226

[9]

CONNEY AH, 1967, PHARMACOL REV, V19, P317

[10] CYTOCHROME P-450-DEPENDENT O-DEALKYLASE ACTIVITY IN MAMMALIAN SKIN [J].

DAMEN, FJM ;

MIER, PD .

BRITISH JOURNAL OF PHARMACOLOGY, 1982, 75 (01) :123-127

← 1 2 3 4 →